11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent | medRxiv

Article usage

Article usage: May 2024 to June 2025

	Abstract	Full	Pdf
May 2024	270	13	60
Jun 2024	64	6	39
Jul 2024	69	5	26
Aug 2024	28	3	18
Sep 2024	32	3	10
Oct 2024	39	10	21
Nov 2024	30	0	11
Dec 2024	24	1	9
Jan 2025	49	2	16
Feb 2025	36	23	5
Mar 2025	64	31	12
Apr 2025	55	7	17
May 2025	117	7	8
Jun 2025	16	3	3

View the discussion thread.

Posted May 10, 2024.

Supplementary Material

Subject Area

Endocrinology (including Diabetes Mellitus and Metabolic Disease)

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)